Company / Cost of Revenue
KESTRA MEDICAL TECHNOLOGIES, LTD. Cost of Revenue History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$35.6M
FY2024
5-year range
$27.5M / $35.6M
FY2023-FY2024
Trend
+29.7%
vs FY2023
Sector context
#108 of 113
Health Care
What the data says
Among 113 Health Care companies, KESTRA MEDICAL TECHNOLOGIES, LTD. is in the top 4% for cost of revenue.
Based on SEC 10-K filings.
$36M in FY2024.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 113This company $35.6M Sector average $11.3B
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, cost of revenue increased 29.7% year-over-year.
- Ranks #108 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $35.6M | +29.7% |
| FY2023 | $27.5M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026